Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial - Döhner, Hartmut; Weber, Daniela; Krzykalla, Julia; Fiedler, Walter; Kühn, Michael W M; Schroeder, Thomas; Mayer, Karin; Lübbert, Michael; Wattad, Mohammed; Götze, Katharina; Fransecky, Lars; Koller, Elisabeth; et al. (The lancet. Haematology, 2023)
Online verfügbar 12 May 2023, Version des Artikels 3 July 2023